publication date: Oct. 22, 2010
In this issue:
• IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria • NCI Sends A Second Letter To Groups About Carboplatin • Agency Asks GnRH Sponsors To Add Warnings On Labels • NCI Awards STRAP Grant Of $2 Million To MSKCC • Beth Israel Suspends Enrollment In Trials Following An Audit • NCCN Guidelines Retain Avastin For Breast Cancer • FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers • “Dollars For Docs” Database Of Pharma Payments Posted By News Organization
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.